OBJECTIVE: We assessed the impact of an extended-spectrum antibiotic prophylaxis regimen (azithromycin in addition to recommended narrow-spectrum cephalosporin) on postcesarean incisional wound infection. STUDY DESIGN: Data from prospective surveillance of surgical site infections at our institution were used to compare incidence in postcesarean incisional wound infection for 3 consecutive time periods of antibiotic prophylaxis: (1) standard (ie, cephalosporin only, 1992-1996); (2) clinical trial of extended spectrum (ie, extended vs cephalosporin only, 1997-1999); and (3) routine use of extended spectrum (2001-2006). RESULTS: The incidence of postcesarean incisional wound infections decreased progressively from 3.1% to 2.4% and then to 1.3% over the 3 consecutive periods (P value for trend < .002). CONCLUSION: Increasing the use of extended-spectrum antibiotic prophylaxis at our institution over 3 time periods was associated with a decreasing trend in postcesarean incisional wound infection.
OBJECTIVE: We assessed the impact of an extended-spectrum antibiotic prophylaxis regimen (azithromycin in addition to recommended narrow-spectrum cephalosporin) on postcesarean incisional wound infection. STUDY DESIGN: Data from prospective surveillance of surgical site infections at our institution were used to compare incidence in postcesarean incisional wound infection for 3 consecutive time periods of antibiotic prophylaxis: (1) standard (ie, cephalosporin only, 1992-1996); (2) clinical trial of extended spectrum (ie, extended vs cephalosporin only, 1997-1999); and (3) routine use of extended spectrum (2001-2006). RESULTS: The incidence of postcesarean incisional wound infections decreased progressively from 3.1% to 2.4% and then to 1.3% over the 3 consecutive periods (P value for trend < .002). CONCLUSION: Increasing the use of extended-spectrum antibiotic prophylaxis at our institution over 3 time periods was associated with a decreasing trend in postcesarean incisional wound infection.
Authors: Amy E Doss; Jennifer D Davidson; Suzanne P Cliver; Luisa A L Wetta; William W Andrews; Alan T N Tita Journal: J Matern Fetal Neonatal Med Date: 2012-05-03
Authors: Lorie M Harper; Meredith Kilgore; Jeff M Szychowski; William W Andrews; Alan T N Tita Journal: Obstet Gynecol Date: 2017-08 Impact factor: 7.661
Authors: R F Lamont; J D Sobel; J P Kusanovic; E Vaisbuch; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero Journal: BJOG Date: 2011-01 Impact factor: 6.531
Authors: Amelia L Sutton; Edward P Acosta; Kajal B Larson; Corenna D Kerstner-Wood; Alan T Tita; Joseph R Biggio Journal: Am J Obstet Gynecol Date: 2015-01-13 Impact factor: 8.661
Authors: Alan T N Tita; Jeff M Szychowski; Kim Boggess; George Saade; Sherri Longo; Erin Clark; Sean Esplin; Kirsten Cleary; Ron Wapner; Kellett Letson; Michelle Owens; Adi Abramovici; Namasivayam Ambalavanan; Gary Cutter; William Andrews Journal: N Engl J Med Date: 2016-09-29 Impact factor: 91.245
Authors: Alan T N Tita; Dwight J Rouse; Sean Blackwell; George R Saade; Catherine Y Spong; William W Andrews Journal: Obstet Gynecol Date: 2009-03 Impact factor: 7.661
Authors: Stephanie L Pierce; Courtney M Bisson; Molly E Dubois; Sarah B Grimes; Mikaela S Katz; Mary M Weed; Sabrina N Wyatt; Erin K Eckart; Jennifer D Peck; Rodney K Edwards Journal: Am J Obstet Gynecol Date: 2021-05-27 Impact factor: 10.693